TY - JOUR
T1 - The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed among Older Men Living with Human Immunodeficiency Virus
AU - Sun, Jing
AU - Brown, Todd T.
AU - Samuels, David C.
AU - Hulgan, Todd
AU - D'Souza, Gypsyamber
AU - Jamieson, Beth D.
AU - Erlandson, Kristine M.
AU - Martinson, Jeremy
AU - Palella, Frank J.
AU - Margolick, Joseph B.
AU - Kirk, Gregory D.
AU - Schrack, Jennifer A.
N1 - Publisher Copyright:
© Oxford University Press.
PY - 2018/8/16
Y1 - 2018/8/16
N2 - Background. Age-related gait speed decline is accelerated in men with human immunodeficiency virus (HIV). Mitochondrial genetic variation is associated with frailty and mortality in the general population and may provide insight into mechanisms of functional decline in people aging with HIV. Methods. Gait speed was assessed semiannually in the Multicenter AIDS Cohort Study. Mitochondrial DNA (mtDNA) haplogroups were extracted from genome-wide genotyping data, classifying men aged =50 years into 5 groups: mtDNA haplogroup H, J, T, Uk, and other. Differences in gait speed by haplogroups were assessed as rate of gait speed decline per year, probability of slow gait speed (<1.0 m/s), and hazard of slow gait using multivariable linear mixed-effects models, mixed-effects logistic regression models, and the Andersen-Gill model, controlling for hepatitis C virus infection, previous AIDS diagnosis, thymidine analogues exposure, education, body composition, smoking, and peripheral neuropathy. Age was further controlled for in the mixed-effects logistic regression models. Results. A total of 455 HIV-positive white men aged =50 years contributed 3283 person-years of follow-up. Among them, 70% had achieved HIV viral suppression. In fully adjusted models, individuals with haplogroup J had more rapid decline in gait speed (adjusted slopes, 0.018 m/s/year vs 0.011 m/s/year, pinteraction = 0.012) and increased risk of developing slow gait (adjusted odds ratio, 2.97; 95% confidence interval, 1.24-7.08) compared to those with other haplogroups. Conclusions. Among older, HIV-infected men, mtDNA haplogroup J was an independent risk factor for more rapid age-related gait speed decline.
AB - Background. Age-related gait speed decline is accelerated in men with human immunodeficiency virus (HIV). Mitochondrial genetic variation is associated with frailty and mortality in the general population and may provide insight into mechanisms of functional decline in people aging with HIV. Methods. Gait speed was assessed semiannually in the Multicenter AIDS Cohort Study. Mitochondrial DNA (mtDNA) haplogroups were extracted from genome-wide genotyping data, classifying men aged =50 years into 5 groups: mtDNA haplogroup H, J, T, Uk, and other. Differences in gait speed by haplogroups were assessed as rate of gait speed decline per year, probability of slow gait speed (<1.0 m/s), and hazard of slow gait using multivariable linear mixed-effects models, mixed-effects logistic regression models, and the Andersen-Gill model, controlling for hepatitis C virus infection, previous AIDS diagnosis, thymidine analogues exposure, education, body composition, smoking, and peripheral neuropathy. Age was further controlled for in the mixed-effects logistic regression models. Results. A total of 455 HIV-positive white men aged =50 years contributed 3283 person-years of follow-up. Among them, 70% had achieved HIV viral suppression. In fully adjusted models, individuals with haplogroup J had more rapid decline in gait speed (adjusted slopes, 0.018 m/s/year vs 0.011 m/s/year, pinteraction = 0.012) and increased risk of developing slow gait (adjusted odds ratio, 2.97; 95% confidence interval, 1.24-7.08) compared to those with other haplogroups. Conclusions. Among older, HIV-infected men, mtDNA haplogroup J was an independent risk factor for more rapid age-related gait speed decline.
KW - HIV
KW - aging
KW - gait speed.
KW - mitochondrial genetic
UR - http://www.scopus.com/inward/record.url?scp=85054979929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054979929&partnerID=8YFLogxK
U2 - 10.1093/cid/ciy151
DO - 10.1093/cid/ciy151
M3 - Article
C2 - 29481608
AN - SCOPUS:85054979929
SN - 1058-4838
VL - 67
SP - 778
EP - 784
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 5
ER -